Stadler T - Search Results

1

A measure of the impact of CV incompleteness on prediction error estimation with application to PCA and normalization.

Hornung R, Bernau C, Truntzer C, Wilson R, Stadler T, Boulesteix AL. Hornung R, et al. Among authors: stadler t. BMC Med Res Methodol. 2015 Nov 4;15:95. doi: 10.1186/s12874-015-0088-9. BMC Med Res Methodol. 2015. PMID: 26537575 Free PMC article.

2

Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase-inhibition with sunitinib.

Staehler M, Haseke N, Schöppler G, Stadler T, Karl A, Siebels M, Ihrler S, Stief CG. Staehler M, et al. Among authors: stadler t. Eur J Med Res. 2008 Nov 24;13(11):531-5. Eur J Med Res. 2008. PMID: 19073390

3

Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation.

Staehler M, Haseke N, Roosen A, Stadler T, Bader M, Siebels M, Karl A, Stief CG. Staehler M, et al. Among authors: stadler t. Eur J Med Res. 2010;15(7):287-91. doi: 10.1186/2047-783x-15-7-287. Eur J Med Res. 2010. PMID: 20696639 Free PMC article. Clinical Trial.

4

Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase inhibition with sunitinib.

Staehler M, Schöppler G, Haseke N, Stadler T, Karl A, Siebels M, Ihrler S, Stief CG. Staehler M, et al. Among authors: stadler t. Clin Genitourin Cancer. 2009 Jan;7(1):58-61. doi: 10.3816/CGC.2009.n.010. Clin Genitourin Cancer. 2009. PMID: 19213670

5

Complete remission achieved with angiogenic therapy in metastatic renal cell carcinoma including surgical intervention.

Staehler M, Haseke N, Zilinberg E, Stadler T, Karl A, Siebels M, Dürr HR, Siegert S, Jauch KW, Bruns CJ, Stief CG. Staehler M, et al. Among authors: stadler t. Urol Oncol. 2010 Mar-Apr;28(2):139-44. doi: 10.1016/j.urolonc.2009.03.033. Epub 2009 Jul 3. Urol Oncol. 2010. PMID: 19576802

6

Plasma N-terminal pro-brain natriuretic peptide as prognostic marker in fatal cardial decompensation with sunitinib malate therapy.

Staehler M, Haseke N, Zilinberg K, Stadler T, Stief CG. Staehler M, et al. Among authors: stadler t. Urol Int. 2010;84(1):119-21. doi: 10.1159/000273480. Epub 2010 Feb 17. Urol Int. 2010. PMID: 20173383 Free article.

7

Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer.

Staehler M, Haseke N, Stadler T, Nuhn P, Roosen A, Stief CG, Wilkowski R. Staehler M, et al. Among authors: stadler t. Urol Oncol. 2012 May-Jun;30(3):290-3. doi: 10.1016/j.urolonc.2010.02.006. Epub 2010 Sep 1. Urol Oncol. 2012. PMID: 20813555

8

[Managing the side effects of angiogenetic inhibitors in metastatic renal cell carcinoma].

Staehler M, Haseke N, Schöppler G, Stadler T, Heinemann G, Stief CG. Staehler M, et al. Among authors: stadler t. Urologe A. 2006 Oct;45(10):1333-42; quiz 1343. doi: 10.1007/s00120-006-1211-7. Urologe A. 2006. PMID: 17021905 Review. German.

9

[Systemic therapy of metastasizing renal cell carcinoma].

Staehler M, Haseke N, Zilinberg K, Stadler T, Karl A, Stief CG. Staehler M, et al. Among authors: stadler t. Urologe A. 2008 Oct;47(10):1357-67. doi: 10.1007/s00120-008-1874-3. Urologe A. 2008. PMID: 18825295 German.

10

[Therapy strategies for advanced renal cell carcinoma].

Staehler M, Haseke N, Schöppler G, Stadler T, Adam C, Stief CG. Staehler M, et al. Among authors: stadler t. Urologe A. 2006 Jan;45(1):99-110, quiz 111-2. doi: 10.1007/s00120-005-0982-6. Urologe A. 2006. PMID: 16372186 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters